Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Pharmacology
  4. Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord

Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord

PLoS ONE, 2015 · DOI: 10.1371/journal.pone.0142598 · Published: November 12, 2015

PharmacologyNeurology

Simple Explanation

Kynurenic acid (KYNA) is a substance in the central nervous system with neuroprotective properties, but its toxic effects were previously unknown. This study aimed to investigate the effects of prolonged exposure to KYNA on the spinal cord. The researchers infused KYNA into the spinal cords of rats for seven days at varying doses and then examined the spinal cord tissue. They found that high doses of KYNA led to myelin damage, which is the protective sheath around nerve fibers. The study suggests that KYNA can be used as a tool to study myelin damage and regeneration. Also, low doses of KYNA may help to discover the role of KYNA in control of physiological myelination process.

Study Duration
7 days
Participants
42 healthy adult Long Evans rats
Evidence Level
Not specified

Key Findings

  • 1
    Continuous subdural KYNA infusion causes dose-dependent myelin damage and myelin loss in the rat spinal cord.
  • 2
    Myelin damage was characterized by separation of lamellae at the intraperiod line, with preservation of axons and no cellular inflammatory response.
  • 3
    Rats infused with higher doses of KYNA showed neurological signs like weakness and quadriplegia, and increased blood MOG concentration, indicating myelin damage.

Research Summary

This study demonstrates that prolonged subdural infusion of KYNA in rats leads to dose-dependent myelin damage in the spinal cord. The myelin damage is characterized by the separation of myelin lamellae, with most axons remaining intact and no signs of inflammation. The severity of myelin damage correlated with the dose of KYNA administered. High doses of KYNA caused neurological deficits such as weakness and quadriplegia, while lower doses resulted in less severe or no noticeable deficits. The researchers suggest that KYNA can be used as an experimental tool for studying myelin damage and regeneration. Additionally, low doses of KYNA could help understand its role in normal myelination processes.

Practical Implications

Experimental Tool for Myelin Research

Subdural infusion of KYNA can be used to study mechanisms of myelin damage and regeneration.

Understanding Physiological Myelination

Low doses of KYNA may help to elucidate the role of KYNA in controlling the physiological myelination process.

Implications for Neurological Disorders

The findings suggest that elevated KYNA levels may contribute to myelin abnormalities observed in neuropsychiatric disorders.

Study Limitations

  • 1
    The sample size for serum MOG level measurements was small.
  • 2
    The study focused on a specific time frame (5-7 days) and did not assess long-term effects.
  • 3
    The exact mechanisms by which KYNA induces myelin damage remain unclear and require further investigation.

Your Feedback

Was this summary helpful?

Back to Pharmacology